Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-25-262703
Filing Date
2025-11-03
Accepted
2025-11-03 16:46:21
Documents
17
Effectiveness Date
2025-11-03

Document Format Files

Seq Description Document Type Size
1 S-8 d45140ds8.htm S-8 77046
2 EX-5.1 d45140dex51.htm EX-5.1 11603
3 EX-23.1 d45140dex231.htm EX-23.1 1528
4 EX-FILING FEES d45140dexfilingfees.htm   iXBRL EX-FILING FEES 12715
5 GRAPHIC g45140dsp001.jpg GRAPHIC 6147
6 GRAPHIC g45140dsp002.jpg GRAPHIC 3852
7 GRAPHIC g45140dsp1.jpg GRAPHIC 5203
  Complete submission text file 0001193125-25-262703.txt   244604

Data Files

Seq Description Document Type Size
19 EXTRACTED XBRL INSTANCE DOCUMENT d45140dexfilingfees_htm.xml XML 5082
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-291229 | Film No.: 251444858
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)